TY - JOUR
T1 - Use of functional aerobic capacity based on stress testing to predict outcomes in normal, overweight, and obese patients
AU - Abudiab, Muaz
AU - Aijaz, Bilal
AU - Konecny, Tomas
AU - Kopecky, Stephen L.
AU - Squires, Ray W.
AU - Thomas, Randal J.
AU - Allison, Thomas G.
PY - 2013/12
Y1 - 2013/12
N2 - Objective: To determine the poorly studied relationship between functional aerobic capacity (FAC) as measured by treadmill stress testing and mortality in normal, overweight, and obese patients. Patients and Methods: Patients were identified retrospectively from the stress testing database at Mayo Clinic in Rochester, Minnesota. We selected 5328 male nonsmokers (mean ± SD age, 51.8±11.5 years) without baseline cardiovascular disease who were referred for treadmill exercise testing between January 1, 1986, and December 31, 1991, and classified them by body mass index (BMI) into normal-weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese (≥30 kg/m2) categories. Functional aerobic capacity was assessed by maximal exercise test results based on age-and sex-specific metabolic equivalents, and patients were stratified into fitness quintiles. Cox proportional hazards analysis was used to determine the relationship of all-cause mortality to fitness in each BMI category. Results: There were 322 deaths during 14 years of follow-up. After adjustment for age and exercise confounders, FAC predicted mortality in the 3 BMI groups. Hazard ratios for FAC less than 80% of predicted vs a reference group with normal BMI and fitness (FAC ≥100%) were 1.754 (95% CI, 0.874-3.522), 1.962 (1.356-2.837), and 1.518 (1.056-2.182) for the normal, overweight, and obese groups, respectively. The CIs of the hazard ratios overlapped with no statistically significant differences (P≥.05). Conclusion: A significant increase in mortality occurs with FAC below 80% of predicted for overweight and obese subjects and below 70% for normal weight subjects. Our results suggest that clinicians need not adjust the standard for low fitness in obese patients.
AB - Objective: To determine the poorly studied relationship between functional aerobic capacity (FAC) as measured by treadmill stress testing and mortality in normal, overweight, and obese patients. Patients and Methods: Patients were identified retrospectively from the stress testing database at Mayo Clinic in Rochester, Minnesota. We selected 5328 male nonsmokers (mean ± SD age, 51.8±11.5 years) without baseline cardiovascular disease who were referred for treadmill exercise testing between January 1, 1986, and December 31, 1991, and classified them by body mass index (BMI) into normal-weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese (≥30 kg/m2) categories. Functional aerobic capacity was assessed by maximal exercise test results based on age-and sex-specific metabolic equivalents, and patients were stratified into fitness quintiles. Cox proportional hazards analysis was used to determine the relationship of all-cause mortality to fitness in each BMI category. Results: There were 322 deaths during 14 years of follow-up. After adjustment for age and exercise confounders, FAC predicted mortality in the 3 BMI groups. Hazard ratios for FAC less than 80% of predicted vs a reference group with normal BMI and fitness (FAC ≥100%) were 1.754 (95% CI, 0.874-3.522), 1.962 (1.356-2.837), and 1.518 (1.056-2.182) for the normal, overweight, and obese groups, respectively. The CIs of the hazard ratios overlapped with no statistically significant differences (P≥.05). Conclusion: A significant increase in mortality occurs with FAC below 80% of predicted for overweight and obese subjects and below 70% for normal weight subjects. Our results suggest that clinicians need not adjust the standard for low fitness in obese patients.
UR - http://www.scopus.com/inward/record.url?scp=84892969141&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892969141&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2013.10.013
DO - 10.1016/j.mayocp.2013.10.013
M3 - Article
C2 - 24290116
AN - SCOPUS:84892969141
SN - 0025-6196
VL - 88
SP - 1427
EP - 1434
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 12
ER -